Resmed (RSMDF) Retained Earnings (2010 - 2026)

Resmed (RSMDF) has reported Retained Earnings for 17 consecutive years, with $7.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings rose 19.3% year-over-year to $7.3 billion; the trailing twelve-month figure through Jun 2026 stood at $7.3 billion (up 19.3% YoY), and the FY2026 full-year result was $7.3 billion, up 19.3% from the prior year.
• Retained Earnings rose to $7.3 billion in Q2 2026 per RSMDF's latest filing, from $7.0 billion in the prior quarter.
• Across five years, Retained Earnings topped out at $7.3 billion in Q2 2026 and bottomed at $3.5 billion in Q1 2022.
• Historically, Retained Earnings has averaged $5.1 billion across 5 years, with a median of $4.9 billion in 2024.
• The sharpest annual moves came in 2023 and 2025: Retained Earnings advanced 15.81% in 2023, then gained 21.83% in 2025.
• Over 5 years, Retained Earnings stood at $3.9 billion in 2022, then increased by 15.81% to $4.5 billion in 2023, then rose by 20.97% to $5.5 billion in 2024, then grew by 21.03% to $6.6 billion in 2025, then increased by 9.14% to $7.3 billion in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $7.3 billion, $7.0 billion, and $6.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.